This asthma drug is capable of blocking coronavirus from replicating [details]

Montelukast has been approved by the US Food and Drug Administration for more than 20 years and is generally recommended to relieve inflammation caused by asthma

Related Keywords

Bangalore ,Karnataka ,India ,Tanweer Hussain ,Sandeep Eswarappa ,Indian Institute Of Science ,Drug Administration ,Department Of Biochemistry ,Iisc Department Of Molecular Reproduction ,Indian Institute ,Molecular Reproduction ,Asthma Drug ,Coronavirus ,Covid ,Asthma Drug Against Coronavirus ,Covid Updates ,Covid News ,Coronavirus News ,Drugs Against Coronavirus ,